Childhood cancer survivors exposed to total body irradiation are at significant risk for slipped capital femoral epiphysis during recombinant growth hormone therapy

Pediatric Blood and Cancer

Volumn 60, Issue 11, 2013, Pages 1766-1771

  Mostoufi Moab, Sogol ^a   Isaacoff, Elizabeth J ^a   Spiegel, David ^a   Gruccio, Denise ^a   Ginsberg, Jill P ^a   Hobbie, Wendy ^a,b   Shults, Justine ^a   Leonard, Mary B ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA SCHOOL OF NURSING   (United States)

Author keywords

Childhood cancer survivors; Cranial irradiation; Growth hormone; SCFE; Total body irradiation

Indexed keywords

RECOMBINANT GROWTH HORMONE;

ADOLESCENT; AGE DISTRIBUTION; ARTICLE; CANCER SURVIVOR; CHILD; CHILDHOOD CANCER; CONTROLLED STUDY; FEMALE; FOLLOW UP; GROWTH HORMONE DEFICIENCY; HORMONAL THERAPY; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SKULL IRRADIATION; SLIPPED CAPITAL FEMORAL EPIPHYSIS; TREATMENT DURATION; WHOLE BODY RADIATION;

CHILDHOOD CANCER SURVIVORS; CRANIAL IRRADIATION; GROWTH HORMONE; SCFE; TOTAL BODY IRRADIATION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HUMAN GROWTH HORMONE; HUMANS; INCIDENCE; INFANT; MALE; NEOPLASMS; RETROSPECTIVE STUDIES; SLIPPED CAPITAL FEMORAL EPIPHYSES; SURVIVORS; WHOLE-BODY IRRADIATION;

EID: 84883751597     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.24667     Document Type: Article

References (41)

1. Loder RT. Slipped capital femoral epiphysis. Am Fam Physician 1998; 57:2135-2142; 2148-2150.
2. Gholve PA, Cameron DB, Millis MB. Slipped capital femoral epiphysis update. Curr Opin Pediatr 2009; 21:39-45.
3. Peck D. Slipped capital femoral epiphysis: Diagnosis and management. Am Fam Physician 2010; 82:258-262.
4. Lehmann CL, Arons RR, Loder RT, et al. The epidemiology of slipped capital femoral epiphysis: An update. J Pediatr Orthop 2006; 26:286-290.
5. Papavasiliou KA, Kirkos JM, Kapetanos GA, et al. Potential influence of hormones in the development of slipped capital femoral epiphysis: A preliminary study. J Pediatr Orthop B 2007; 16:1-5.
6. Wabitsch M, Horn M, Esch U, et al. Silent slipped capital femoral epiphysis in overweight and obese children and adolescents. Eur J Pediatr 2012; 171:1461-1465.
7. Shank CF, Thiel EJ, Klingele KE. Valgus slipped capital femoral epiphysis: Prevalence, presentation, and treatment options. J Pediatr Orthop 2010; 30:140-146.
8. Felicetti F, Manicone R, Corrias A, et al. Endocrine late effects after total body irradiation in patients who received hematopoietic cell transplantation during childhood: A retrospective study from a single institution. J Cancer Res Clin Oncol 2011; 137:1343-1348.
9. Chow EJ, Liu W, Srivastava K, et al. Differential effects of radiotherapy on growth and endocrine function among acute leukemia survivors: A childhood cancer survivor study report. Pediatr Blood Cancer 2013; 60:110-115.
10. Isfan F, Kanold J, Merlin E, et al. Growth hormone treatment impact on growth rate and final height of patients who received HSCT with TBI or/and cranial irradiation in childhood: A report from the French Leukaemia long-term follow-up study (LEA). Bone Marrow Transplant 2012; 47:684-693.
11. Darendeliler F, Karagiannis G, Wilton P. Headache, idiopathic intracranial hypertension, and slipped capital femoral epiphysis during growth hormone treatment: A safety update from the KIGS database. Horm Res 2007; 68:41-47.
12. Loder RT, Hensinger RN, Alburger PD, et al. Slipped capital femoral epiphysis associated with radiation therapy. J Pediatr Orthop 1998; 18:630-636.
13. Fletcher BD, Crom DB, Krance RA, et al. Radiation-induced bone abnormalities after bone marrow transplantation for childhood leukemia. Radiology 1994; 191:231-235.
14. Boero S, Brunenghi GM, Carbone M, et al. Pinning in slipped capital femoral epiphysis: Long-term follow-up study. J Pediatr Orthop B 2003; 12:372-379.
15. Bell J, Parker KL, Swinford RD, et al. Long-term safety of recombinant human growth hormone in children. J Clin Endocrinol Metab 2010; 95:167-177.
16. Rennie W, Mitchell N. Slipped femoral capital epiphysis occurring during growth hormone therapy. Report of a case. J Bone Joint Surg Br 1974; 56-B:703-705.
17. Fidler MW, Brook CG. Slipped upper femoral epiphysis following treatment with human growth hormone. J Bone Joint Surg Am 1974; 56:1719-1722.
18. August GP, Lippe BM, Blethen SL, et al. Growth hormone treatment in the United States: Demographic and diagnostic features of 2331 children. J Pediatr 1990; 116:899-903.
19. Blethen SL, Allen DB, Graves D, et al. Safety of recombinant deoxyribonucleic acid-derived growth hormone: The National cooperative growth study experience. J Clin Endocrinol Metab 1996; 81:1704-1710.
20. Maneatis T, Baptista J, Connelly K, et al. Growth hormone safety update from the National cooperative growth study. J Pediatr Endocrinol Metab 2000; 13:1035-1044.
21. Kemp SF, Kuntze J, Attie KM, et al. Efficacy and safety results of long-term growth hormone treatment of idiopathic short stature. J Clin Endocrinol Metab 2005; 90:5247-5253.
22. Bolar K, Hoffman AR, Maneatis T, et al. Long-term safety of recombinant human growth hormone in turner syndrome. J Clin Endocrinol Metab 2008; 93:344-351.
23. Haidar RK, Nasrallah MP, Der-Boghossian AH, et al. Orthopedic complications related to growth hormone therapy in a pediatric population. J Pediatr Orthop Part B 2011; 20:57-61.
24. Fine RN, Ho M, Tejani A, et al. Adverse events with rhGH treatment of patients with chronic renal insufficiency and end-stage renal disease. J Pediatr 2003; 142:539-545.
25. Harris WR. The endocrine basis for slipping of the upper femoral epiphysis. An experimental study. J Bone Joint Surg 1950; 32-B:5-11.
26. Clayton PE, Cowell CT. Safety issues in children and adolescents during growth hormone therapy-A review. Growth Horm IGF Res 2000; 10:306-317.
27. Rappaport EB, Snoy P, Habig WH, et al. Effects of exogenous growth hormone on growth plate cartilage in rats. Am J Dis Child 1987; 141:497-501.
28. Dickerman JD, Newberg AH, Moreland MD. Slipped capital femoral epiphysis (SCFE) following pelvic irradiation for rhabdomyosarcoma. Cancer 1979; 44:480-482.
29. Sabio H, Sussman M, Levien M. Postradiation slipped capital femoral epiphyses (SCFE). J Surg Oncol 1987; 36:45-47.
30. Rubin P, Casarett GW. Clinical radiation pathology as applied to curative radiotherapy. Cancer 1968; 22:767-778.
31. Ryan BR, Walters TR. Slipped capital femoral epiphysis following radiotherapy and chemotherapy. Med Paediatr Oncol 1979; 6:279-283.
32. Barrett IR. Slipped capital femoral epiphysis following radiotherapy. J Pediatr Orthop 1985; 5:268-273.
33. Kelsey JL. Epidemiology of slipped capital femoral epiphysis: A review of the literature. Pediatrics 1973; 51:1042-1050.
34. Loder RT, Starnes T, Dikos G, et al. Demographic predictors of severity of stable slipped capital femoral epiphyses. J Bone Joint Surg Am 2006; 88:97-105.
35. Mannof E, Banffy M, Winell J. Relationship between body mass index and slipped capital femoral epiphysis. J Pediatr Orthop 2005; 25:744-746.
36. Poussa M, Schlenzka D, Yrjonen T. Body mass index and slipped capital femoral epiphysis. J Pediatr Orthop Part B 2003; 12:369-371.
37. Muller W. Die entstehung von coxa valga durch epiphysenverschiebung. Beitr Klin Chir 1926; 28:869-872.
38. Loder RT, O'Donnell PW, Didelot WP, et al. Valgus slipped capital femoral epiphysis. J Pediatr Orthop 2006; 26:594-600.
39. Venkatadass K, Shetty AP, Rajasekaran S. Valgus slipped capital femoral epiphysis: Report of two cases and a comprehensive review of literature. J Pediatr Orthop Part B 2011; 20:291-294.
40. Klein A, Joplin RJ, Reidy JA, et al. Slipped capital femoral epiphysis; early diagnosis; and treatment facilitated by normal roentgenograms. J Bone Joint Surg Am 1952; 34-A:233-239.
41. Segal LS, Weitzel PP, Davidson RS. Valgus slipped capital femoral epiphysis. Fact or fiction? Clin Orthop Relat Res 1996; 322:91-98.